IP Library › Granted Patent US 12,156,945
Granted Patent B2
US 12,156,945 · App. 18/114,909 · Granted Dec 3, 2024

Precision pharmaceutical 3D printing device

Inventors: Xiaoling Li (Dublin, CA); Haohui Lu (Nanjing, CN); Wei Wu (Nanjing, CN); Haili Liu (Nanjing, CN); Senping Cheng (Nanjing, CN); Renjie Li (Nanjing, CN); Yang Liu (Nanjing, CN); Feihuang Deng (Nanjing, CN)
Assignee: TRIASTEK, INC.
A61K9/2095B29C64/106B29C64/118B29C64/171B29C64/209B29C64/295B29C64/321B29C64/336B29C64/393B33Y10/00B33Y30/00B33Y50/02B33Y70/00B33Y80/00B29K2001/08B29K2033/12B29K2039/06B29K2105/0035B29L2031/753B33Y40/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,156,945
App. No.
18/114,909
Granted
Dec 3, 2024
Kind
B2
Abstract

Provided herein are devices and systems for depositing a material or manufacturing a product, such as a pharmaceutical dosage form, by additive manufacturing. Further provided are methods of using the devices and systems, as well as methods of manufacturing a product, such as a pharmaceutical dosage form, by additive manufacturing. In certain embodiments, the device includes a material supply system configured to melt an pressurized a material, a pressure sensor configured to detect a pressure of the material within the device, and a control switch comprising a sealing needle operable in an open position and closed position. The sealing needle extends through a feed channel containing the material and includes a taper end, wherein the tapered end of the sealing needle engages a tapered inner surface of a nozzle to inhibit flow of the material through the nozzle when the sealing needle is in the closed position.

Claims (34)

1. A method of manufacturing a pharmaceutical product by additive manufacturing, comprising:

melting and pressurizing a material;

flowing the material through an extrusion port of a nozzle comprising a tapered inner surface;

engaging a tapered end of a sealing needle with the tapered inner surface of the nozzle, thereby sealing the extrusion port and stopping flow of the melted material;

withdrawing the tapered end of the sealing needle, thereby resuming flow of the material through the extrusion port;

heating the material in a printing head comprising the nozzle using one or more heaters;

wherein a material supply system comprises a barrel and a feed channel connecting the barrel to the printing head; and

heating the material in the barrel, wherein the material is heated in the printing head to a temperature above the temperature of the material heated in the barrel.

2. The method of claim 1 , comprising receiving instructions for manufacturing the product.

3. The method of claim 1 , wherein:

the product is a pharmaceutical dosage form; and

the material is a pharmaceutically acceptable material.

4. The method of claim 3 , wherein the pharmaceutically acceptable material comprises a drug.

5. The method of claim 4 , wherein the pharmaceutical dosage form has a desired drug release profile.

6. The method of claim 3 , comprising receiving instructions for manufacturing the pharmaceutical dosage form.

7. The method of claim 3 , wherein the tapered end of the sealing needle is withdrawn to a selected open distance between a maximum open position and a closed position.

8. The method of claim 3 , comprising heating the material in a printing head comprising the nozzle using one or more heaters.

9. The method of claim 8 , wherein a material supply system comprises a barrel and a feed channel connecting the barrel to the printing head.

10. The method of claim 9 , further comprising heating the material in the barrel.

11. The method of claim 10 , wherein the material is heated in the printing head to a temperature above the temperature of the material heated in the barrel.

12. The method of claim 3 , wherein the tapered end of the sealing needle comprises a frustoconical tip.

13. The method of claim 3 , wherein the tapered end of the sealing needle comprises a pointed tip.

14. The method of claim 3 , wherein the material has a viscosity of about 100 Pa″s or more when extruded from the extrusion port.

15. The method of claim 3 , wherein the sealing needle is operable in an open position between a maximum open position and a closed position.

16. The method of claim 1 , comprising heating the material in a printing head comprising the nozzle using one or more heaters.

17. The method of claim 1 , wherein the material supply system comprises a barrel and a feed channel connecting the barrel to the printing head.

18. The method of claim 17 , further comprising heating the material in the barrel.

19. The method of claim 18 , wherein the material is headed in the printing head to a temperature above the temperature of the material heated in the barrel.

20. A method of manufacturing a pharmaceutical product by additive manufacturing, comprising:

melting and pressurizing a first material;

flowing the first material through a first extrusion port of a first nozzle comprising a tapered inner surface;

engaging a tapered end of a first sealing needle, thereby sealing the first extrusion port and stopping flow of the melted first material;

melting and pressurizing a second material; and

withdrawing a tapered end of a second sealing needle, thereby initiating flow of the second material through a second extrusion port.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2023
From: LI, XIAOLING; LU, HAOHUI; WU, WEI; LIU, HAILI; CHENG, SENPING; LI, RENJIE; LIU, YANG; DENG, FEIHUANG
To: TRIASTEK, INC.
Reel/Frame 063485/0574 →
Priority Claims (1)
WO PCT/CN2018/071965 · Jan 9, 2018 · international
Continuity (3)
Division 16923933 · Jul 8, 2020
Continuation PCTCN2019070634 · Jan 7, 2019
Related Publication 20230225978A1 · Jul 20, 2023
Cited By (3)
US 12,324,856 US 12,595,084 US 12,605,881